The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer:

Franziska Büscheck,Maciej Zub,Asmus Heumann,Claudia Hube-Magg,Ronald Simon,Dagmar S. Lang,Doris Höflmayer,Emily Neubauer,Frank Jacobsen,Andrea Hinsch,Andreas M. Luebke,Maria Christina Tsourlakis,Guido Sauter,Hartwig Huland,Markus Graefen,Alexander Haese,Hans Heinzer,Torsten Schlomm,Till S. Clauditz,Eike Burandt,Waldemar Wilczak,Stefan Steurer,Sarah Minner

The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer:

2019

GATA2 is a pioneering transcription factor governing androgen receptor expression and signaling in prostate cells. To understand the prognostic potential of GATA2 assessment in prostate cancer, we ...

Keywords:

Prostate
Cancer research
Biology
GATA2
Transcription factor
Androgen receptor
Prostate cancer
Erg
Biochemical recurrence
Androgen
TMPRSS2

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations